Aurobindo Pharma is currently trading at Rs. 1135.50, up by 12.60 points or 1.12% from its previous closing of Rs. 1122.90 on the BSE. The scrip opened at Rs. 1135.05 and has touched a high and low of Rs. 1159.35 and Rs. 1130.25 respectively. So far 62567 shares were traded on the counter. The BSE … Read more
Aurobindo Pharma has reported results for second quarter ended September 30, 2018. The company has reported a fall of 49.40% in its net profit at Rs 380.95 crore for the quarter under review as compared to Rs 752.83 crore for the same quarter in the previous year. However, total income of the company increased by … Read more
Aurobindo Pharma’s wholly owned subsidiary — Aurobindo Pharma USA Inc. — has entered into an agreement to acquire a product under development and related assets from Advent Pharmaceuticals Pty, Australia, through AuroScience Pty, Melbourne, a 100% subsidiary of Aurobindo Pharma USA Inc. This acquisition will provide an opportunity to acquire assets that would be used … Read more
